Daunorubicin injection(Qingyuan Wuyue Biomedical)

柔红霉素注射液(清远五岳生物)

Report date: 2026/03/04 20:01:44

Base Information

Drug NameDaunorubicin injection(Qingyuan Wuyue Biomedical)
Drug Alias Name柔红霉素注射液(2.2类改良型)Cerubidine
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A